(also known as array genomic comparative hybridization, or array CGH) with established diagnostic procedures including G-banded karyotype and fragile X testing.
Arrays for CMA tests are widely available, but have not yet entered general practice to the extent that generally agreed standards and references exist. Applying CMA to the entire genomes of 697 ASD patients, Shen et al. detected clinically relevant CNVs in 51 individuals (7.3%). Targeting the method at the most promising genomic regions with a smaller group of patients, they only had a discovery rate of 5.3%, but in both cases the yields are much higher than for established chromosomal tests.
These authors conclude that "CMA had the highest detection rate among clinically available genetic tests for patients with ASD". Therefore, they recommend, "CMA should be considered as part of the initial diagnostic evaluation of patients with ASD". The International Standard Cytogenomic Array (ISCA) consortium conducted a literature review and came to the same conclusion (Am. J. Hum. Genet. (2010) 86, 749) .
Still, the analysis by Shen et al. detected clinically relevant CNVs in only 7.3% of the ASD patients tested, and the specific significance of those found remains uncertain. As none of the diagnostic results suggests any treatment options, there is no immediate benefit to the patients. They may benefit indirectly in the long term, as more data accumulate and scientists gain a better understanding. Patients' families may benefit from finding out whether the specific case is associated with a de novo event or an inherited variation, which can drastically change the recurrence risk for future offspring of both the parents and unaffected siblings.
Clinical testing may in the long term also help to clarify the boundaries of the autistic spectrum and get a more reliable measure of its prevalence. An indication regarding the extent to which these issues are still in flow has emerged recently with a study conducted in South Korea which claimed a surprisingly high prevalence of ASD of 2.64% (3.74% for boys and 1.47% for girls), based on a screening of over 55,000 children aged 7 to 12 (Am. J. Psychiatry, doi: 10.1176 Psychiatry, doi: 10. /appi. ajp.2011 .
Young Shin Kim and co-workers at Yale went through a case identification process involving several steps and addressing the entire population of 7-to 12-year-olds in the community they studied. An initial screening covering both regular schools and special-needs schools yielded around 2,000 potential candidates, of whom 286 were assessed for ASD. Of these assessments, 201 returned a positive diagnosis for ASD. As there were inevitable losses along the way of families who didn't respond or failed to consent to the assessment, the authors have had to use statistical extrapolation to arrive at the reported prevalence rates.
Beyond statistical uncertainties, these findings raise all kinds of questions as to where to draw the line between ASD and 'normal', whether the condition is still widely underdiagnosed, and whether prevalence is still increasing.
Nearly seventy years after Leo Kanner first recognised and described autism, its scientific understanding is still very much at the beginning. What are brown algae? Brown algae or brown seaweeds are the dominant organisms in many of the world's coastal regions, where they are responsible for the bulk of primary production, often forming extensive undersea forests that host a high level of biodiversity. From an evolutionary point of view, brown algae are members of the stramenopiles (or heterokonts), a group that has been evolving independently of the well-studied animal, fungal and green plant lineages for over a billion years. As a result of this unique evolutionary history, these organisms exhibit many novel features. For example, they represent one of a very limited number of eukaryotic groups that have independently evolved complex multicellularity. Brown algae also exhibit some remarkable characteristics in terms of their cell biology; cytokinesis, for example, having features typical of both animals (centrosomes) and green plants (centrifugal cell plate formation). Moreover, since their divergence from other eukaryotic groups, brown algae have evolved several innovative metabolic processes, making them highly interesting targets for the discovery of novel biomolecules for industrial use. There is also increasing interest in the use of brown algae as a source of biomass for fuel production due to their very rapid growth rates and the fact that cultivation does not compete with food crops for the use of arable land. The giant kelp Macrocystis pyrifera, for example, is one of the largest and most rapidly growing organisms on the planet, reaching lengths of up to 60 metres.
Has a model organism been developed to study all these interesting aspects of brown algal biology? Yes, the small, filamentous brown alga Ectocarpus was proposed as a model organism for the brown algae about seven years ago and a number of genetic and molecular tools have been developed for this organism. Available tools include a considerable amount of cDNA and small RNA sequence data,
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various types of microarrays, genetic methodologies and a genetic map. A transformation protocol, gene silencing techniques and a population adapted to the reverse genetic TILLING (Targeting Induced Local Lesions in Genomes) technique are under development.
Why was Ectocarpus chosen as the model for this group of organisms?
The choice of Ectocarpus was based primarily on the fact that, in contrast to the much larger kelps, this small, filamentous alga is well adapted for genetic and genomic approaches. The life cycle of Ectocarpus is relatively short (3-4 months) and can be completed in the laboratory using simple culture conditions (Figure 1 ). Genetic techniques, such as crosses and mutant screens are also possible. Strains can be grown axenically and can be maintained for long-term storage under low light conditions, and many ecotypes are available. Importantly, though, despite their relatively simple morphology, the Ectocarpales are one of the more recently evolved brown algal groups and are closely related to complex kelps of the group Laminariales. Information obtained using Ectocarpus as a model organism should therefore be relevant to the economically and ecologically important kelps. Do we have a genome sequence for Ectocarpus? Yes, the complete genome sequence was published last year. As might have been expected, given the atypical evolutionary origin of this organism, the genome exhibits a number of remarkable features. For example, the genes are split into many short exons separated by long introns, and intergenic regions are often very short. One consequence of this is that intron sequence constitutes an unusually large proportion (40%!) of the genome.
What biological processes can
Ectocarpus be used to study? Work on Ectocarpus dates back to the 19th century. Investigators initially concentrated on understanding its life cycle, which involves alternation between two independent, multicellular generations, the sporophyte and the gametophyte. Later work led to the characterisation of the pheromone that is produced by the female gamete to attract male gametes and to the characterisation of a giant DNA virus, EsV-1, which integrates into the alga's nuclear genome following infection.
Current research programs investigate several aspects of Ectocarpus biology. The life cycle continues to be an important area of study, with modern genetic methods now being employed to investigate the molecular mechanisms that underlie key life cycle transitions. For example, mutants have been obtained in which the alternation between the sporophyte and gametophyte generations is perturbed. Other active areas of study include sex determination, morphogenesis, gamete recognition, various aspects of metabolism, including carbon storage and cell wall biosynthesis, and responses to both biotic and abiotic stress.
You mentioned complex multicellularity. What is known about how this evolved in the brown algae?
Only five of the many phylogenetic groups of eukaryotic organisms are considered to have evolved complex multicellularity, which can be defined as the deployment of a developmental program that involves the creation of distinct organs made up of multiple different cell types. These five groups are the animals, green plants/algae, the fungi, the red algae and the brown algae. Multicellularity emerged independently in each of these groups, so that each can be considered to represent an individual evolutionary 'experiment' and comparative analysis of the five lineages is expected to provide insights into the fundamental molecular processes underlying this key evolutionary transition. Unfortunately, very little is known about how developmental processes work in several of these groups, including the brown algae. The Ectocarpus genome sequence therefore presented an unparalleled opportunity to obtain some clues about how multicellularity might have emerged in this lineage. Analysis of the genome sequences has identified several potentially important features, including the retention of key genes and gene families and the emergence of novel gene families. One particularly striking discovery was the identification of a family of membrane-localised receptor kinases, which is absent from unicellular members of the stramenopiles, such as the diatoms. Both animals and green plants possess families of membranelocalised receptor kinases. Importantly, not only do these molecules appear to have functions that are related to multicellular development, but they are encoded by gene families that evolved independently in the two lineages and their emergence may have been a key step along the path to multicellularity. Phylogenetic analysis of the Ectocarpus receptor kinase family indicated that it too evolved independently, substantially reinforcing the link between the invention of receptor kinases and the transition to multicellularity.
Where can I find out more?
Charrier, B., Coelho, S.M., Le Bail, A., Tonon, T., Michel, G., Potin, P., Kloareg, B., Boyen, C., Peters, A. ugent.be/webtools/bogas/ but with growing unease because I had come to believe they were fields on the margins of science, going nowhere. Problems were endlessly debated, but rarely, if ever, solved. I wanted to be in mainstream science and to solve problems. Vision seemed promising because it had in the past attracted great scientists like Newton, Helmholtz and Mach, and was blooming because of Hubel and Wiesel's Nobel Prize. Psychophysics was becoming a respectable way of doing science.
By a lucky accident (my mother always said I was lucky) I had put together a system from a miniscule PDP8 computer (all of 16K of memory) and point-plotting oscilloscopes to help visualize multidimensional structures, using stereopsis to present them in three dimensions rather than the usual two, and rotating them. I realized that the system and the methods I had developed could be used to make dynamic (or stochastic) versions of the Hungarian polymath Bela Julesz's remarkable random dot stereograms, with very accurate and precise control of space and time. I think it was unique at the time and may still be.
How did you gain traction?
Having papers published early on in good journals helped, so too did attracting research funding. Julesz noticed what I was publishing and, intrigued that such work could be done in so remote a corner of the world as Perth, invited me to work with him at the Bell Labs, then a research powerhouse. Subsequently he came to work with me in Perth.
I also made contact with physiologist Fergus Campbell who arranged for me to spend a year at Cambridge in his lab, where I resided in the lap of luxury as a fellow of his college (St John's). He too came to Perth. These two top, quirky, outrageous, most generous but mutually suspicious vision scientists gave me the leg up I needed.
David 
